Update: A newly published evaluation of the RTS,S malaria vaccine has demonstrated a measurable reduction in child mortality across Malawi, Ghana, and Kenya. According to Punch Healthwise, the latest findings published in The Lancet and confirmed by the World Health Organisation indicate that an estimated one in eight child deaths were averted among eligible recipients over a four-year period. WHO Director of Immunisation, Vaccines and Biologicals Kate O'Brien stated that the study offers clear evidence that the vaccine can reliably reduce child mortality on the continent. The report also noted that the four-dose vaccination schedule has created additional opportunities for health workers to provide other essential childhood interventions, such as vitamin A supplementation and insecticide-treated nets.
In separate health policy news, a recent multi-country analysis of WHO STEPS survey data has identified Malawi as a regional leader in cervical cancer screening uptake. The study, published on medRxiv, examined the structural constraints and fragmented service delivery that often hinder screening access across Africa. Researchers highlighted that Malawi, along with Botswana and Eswatini, has achieved better overall screening coverage by successfully integrating cervical cancer prevention into existing primary care and HIV treatment services.